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Aim. To clarify the endoscopic mucosal change of the stomach caused by Lugol’s iodine solution spray on screening esophago-
gastroduodenoscopy (EGD). Methods. Sixty-four consecutive patients who underwent EGD for esophageal squamous cell
carcinoma screening were included in this study. The records for these patients included gastric mucosa ﬁndings before and after
Lugol’s iodine solution was sprayed. The endoscopic ﬁndings of the greater curvature of the gastric body were retrospectively
analyzed based on the following ﬁndings: fold thickening, exudates, ulcers, and hemorrhage. Results. Mucosal changes occurred
after Lugol’s solution spray totally in 51 patients (80%). Fold thickening was observed in all 51 patients (80%), and a reticular
pattern of white lines was found on the surface of the thickened gastric folds found in 28 of the patients (44%). Exudates were
observed in 6 patients (9%). Conclusion. The gastric mucosa could be aﬀected by Lugol’s iodine; the most frequent endoscopic
ﬁnding of this eﬀect is gastric fold thickening, which should not be misdiagnosed as a severe gastric disease.
1.Introduction
It is widely accepted that chromoendoscopy using Lugol’s
iodine solution is eﬀective for the detection of esophageal
squamous cell carcinomas. Mature squamous epithelia,
which contain glycogen, are stained deeply by iodine, while
mucosal lesions such as dysplasias or carcinomas, which
contain little or no glycogen, remain unstained in contrast to
the surrounding mucosa [1–4]. Lugol’s iodine, however, can
induce mucosal irritation, leading to retrosternal pain and
discomfort, and can even induce erosion or ulceration in the
esophagusandstomach[1,5,6].Therehavebeenseveralcase
reports of esophageal and gastric injury caused by Lugol’s
iodine [5–7]. In spite of these facts, actual mucosal changes
or damage caused by Lugol’s iodine solution have not been
suﬃciently documented and remain unclear.
The aim of our study was to clarify the endoscopic
mucosal change of the stomach caused by Lugol’s iodine
solution spray on screening esophagogastroduodenoscopy
(EGD).
2.MaterialsandMethods
2.1. Patients. Sixty-four consecutive patients (54 men and
10 women; age range, 36–80 years; mean age 64 years) who
u n d e r w e n tE G Df o re s o p h a g e a ls q u a m o u sc e l lc a r c i n o m a
screening during the period from March 2007 to March 2008
at the Department of Clinical Radiology, Kyushu University
Hospital, Fukuoka, Japan, were included in this study. The
records for these patients included gastric mucosa ﬁndings
before and after Lugol’s iodine solution was sprayed. The
patients’ proﬁles are shown in Table 1. Written informed
consent was obtained from all patients before endoscopic
examination. Patients with stomach illness such as gastric
malignancies,rugaehypertrophy,ulcers,postoperativestom-
ach, and acute gastritis were excluded from this study.2 Gastroenterology Research and Practice
Table 1: The clinical characteristics of the patients (n = 64).
Age, mean y (SD) 64 (10)
Sex, male, n (%) 54 (84)
Reason for screening endoscopy, n (%)
Previous malignancy
Esophageal cancer 23 (36)
Pharyngeal cancer 18 (28)
Tongue cancer 9 (14)
Laryngeal cancer 4 (6)
Oral cavity cancer 3 (5)
Other 7 (11)
2.2. Endoscopic Examination. The endoscopies were per-
formed by three experienced endoscopists using standard
endoscopes(GIF-KQ240,GIF-Q260,orGIF-H260;Olympus
Optical Co, Ltd, Tokyo, Japan). Patients were given premed-
ication with local pharyngeal anesthesia and diazepam (5–
10mg intravenously) if needed and were placed in the left
lateral decubitus position. The endoscopic procedure was as
follows:
(1) routine examination of the esophagus, stomach, and
proximal duodenum,
(2) examination of the esophagus using 10mL of 3%
Lugol’s iodine solution (6g of I and 12g of KI
in 500mL water) spray administered by a hand-
controlled syringe via the working channel of the
endoscope over the entire esophagus, followed by
the spraying of 20mL of 20% sodium thiosulfate
solution (STS; 10% Detoxol, Banyu Pharmaceutical,
Co., LTD., Tokyo, Japan) in order to neutralize the
Lugol’s iodine solution,
(3) aspiration of the residual agent of the stomach via
the working channel, followed by reexamination of
the stomach under the same conditions as before the
Lugol’s solution spray was administered. The time
interval between Lugol’s iodine spray and reexamina-
tion was 64–970 (mean; 174) seconds.
Endoscopic examination records and their pictures were
retrospectively analyzed. The endoscopic ﬁndings of the
greater curvature of the gastric body where the agent had
collected were evaluated based on the following ﬁndings:
fold thickening, exudates, ulcers, and hemorrhage. The
association of the mucosal changes with the time that
Lugol’s solution was in contact with the gastric mucosa
was also analyzed using Student’s t-test. Endoscopic biopsy
specimens, if associated with the mucosal changes, were
reviewed for histological conﬁrmation.
3. Results andDiscussion
3.1. Results. Mucosal changes of the greater curvature of the
gastric body occurred after Lugol’s solution spray totally in
51 patients (80%). Fold thickening was observed in all 51
patients (80%), and a reticular pattern of white lines was
(a)
(b)
Figure 1: Gastric mucosal changes occurred after splaying Lugol’s
iodine solution in a 78-year-old man. (a) Endoscopic view of the
greater curvature of the gastric body showed no fold thickening. (b)
Endoscopic view after spraying Lugol’s iodine solution showed fold
thickening.
foundonthesurfaceofthethickenedgastricfoldsin28ofthe
patients (44%). Exudates were observed in 6 patients (9%).
No ulcers, hemorrhage, or other complications occurred
during the endoscopic examination in this study (Table 2).
The characteristic endoscopic ﬁndings are shown in Figures
1 and 2. The mean time intervals between Lugol’s solution
spray and reexamination were 166 ± 156 seconds for
positive mucosal changes group and 206 ± 248 seconds for
negative group, which presented no signiﬁcant diﬀerence
(P = .109). No biopsy specimens were obtained from the
stomach after spraying with Lugol’s solution. Esophageal
biopsies were performed in 8 patients for lesions that were
suspicious of malignancy after spraying Lugol’s solution, but
no pathological lesions that could be attributed to the agent
were found. There were no other unusual esophageal lesions
found during the endoscopic procedures, and there were
no esophageal or gastric adverse events identiﬁed clinically
within 48 hours of any of the cases.
3.2. Discussion. Drug-induced gastritis, although rare, is
known as an etiology of noninfective gastritis. Numerous
drugs including iron, colchicine, kayexalate in sorbitolGastroenterology Research and Practice 3
Figure 2: Gastric mucosal changes caused by Lugol’s solution in
a 58-year-old man. The reticular pattern of white lines on the
thickened folds is shown by the arrows.
Table 2: Endoscopic ﬁndings of the greater curvature of the gastric
body after spraying Lugol’s iodine solution.
Endoscopic ﬁndings (n = 64) n (%)
Thickened folds 51 (80)
Reticular pattern 28 (44)
Exudates 6 (9)
Ulcers 0 (0)
Hemorrhage 0 (0)
and various chemotherapeutic agents have been associated
with gastric mucosal changes [8]. However, Lugol’s iodine
solution has not been generally recognized as potentially
toxic for the gastric mucosa. Free iodine can cause mucosal
irritationleadingtoretrosternalpainanddiscomfortandcan
even result in erosions or ulcers in the esophagus and/or the
stomach [1]. There are several case reports of esophageal and
gastric injury caused by Lugol’s iodine [5–7].
In our study, endoscopically evident gastric mucosal
changes appeared after the spraying of Lugol’s iodine solu-
tion in 80% of the patients, consistent with a direct eﬀect of
Lugol’s iodine on the gastric mucosa. Thickened gastric folds
were the most frequent mucosal change seen. Sreedharan
et al. reported a case of gastric mucosal damage during
Lugol’s chemoendoscopy which showed a similar endoscopic
appearance, and their biopsy specimens showed acute edema
of the gastric lamina propria with loss of the superﬁcial
epitheliumbutnoinﬂammatoryinﬁltrate,consistentwithan
acute toxic gastric mucosal injury induced by Lugol’s iodine
solution [7]. They found these changes only in the greater
curvature of the gastric body, where the Lugol’s solution
pools during the EGD exam. We analyzed the mucosal
changes caused by Lugol’s solution in the greater curvature
of the gastric body on the basis of their results. We did
not have endoscopic data from other parts of the stomach.
The endoscopic appearance of the esophagus showed no
abnormalities that could be attributed to the spraying
of Lugol’s solution. These results may indicate that, as
Sreedharan et al. proposed, the gastric columnar epithelium
may be more susceptible to the toxic eﬀect of Lugol’s iodine
than the squamous esophageal mucosa. Another patient,
reportedbyParketal.,hadmuchmoresevereesophagealand
gastric injury after Lugol’s spraying, and they hypothesized
that this extreme damage might have been caused by a
hypersensitivity reaction [5]. However, our results indicated
that the mucosal changes that appeared after Lugol’s solution
spray were not associated with a hypersensitivity reaction
because of our negative esophageal ﬁndings.
Sreedharan et al. suggested aspirating the gastric pool as
soon as possible after spraying with Lugol’s, before exam-
ining the esophagus, to reduce the toxic eﬀects. However,
we found no signiﬁcant diﬀerence between the incidence of
gastric mucosal changes and the exposure time of Lugol’s
solution in our study.
Fold thickening is well known as one of the endoscopic
ﬁndings of major gastric disease. The causes of gastric fold
thickening are protein-losing gastropathy with hypertrophic
gastric folds (PLGH) including Menetrier’s disease, anisaki-
asis, acute gastric mucosal lesions, gastric lymphoma, and
scirrhous carcinoma [9, 10]. Acute gastric fold thickening
induced by Lugol’s iodine solution should be recognized as a
minor iatrogenic disorder that might be confused with these
more serious conditions.
A reticular pattern of white lines on the swollen gastric
folds was seen in 44% of the patients. This may have indi-
cated severe interstitial edema of the columnar epithelium,
because it was most frequently seen in the more thickened
folds. However, it must remain a hypothesis and cannot
be tested because endoscopic measuring or pathological
correlation was not available in this retrospective study.
Kondo et al. reported that sodium thiosulphate solution
spray (STS) neutralized free iodine and reduced the symp-
toms induced by Lugol’s iodine [1]. In the present study,
the gastric mucosal change might be somewhat aﬀected
by STS because endoscopic evaluation was performed after
STS spraying. Therefore, both endoscopic and pathological
investigations without STS are needed in order to verify the
actual eﬀects of Lugol’s iodine on the gastric mucosa.
Our study has two limitations mentioned above. First,
the pathological correlation was absent. Second, accurate
evaluation of swollen gastric folds was diﬃcult because it
would be inﬂuenced by gas distention.
We might have to consider designing a prospective study
to collect the data needed to further evaluate the causes
of the post-Lugol’s changes and to propose the prevention
strategies.
4. Conclusions
In conclusion, it is important to be aware that the gastric
mucosa could be aﬀected by Lugol’s iodine, and that the
most frequent endoscopic ﬁnding of this eﬀect is gastric
fold thickening. Therefore, endoscopists should take into
consideration the possibility of this adverse eﬀect and4 Gastroenterology Research and Practice
examine the stomach before spraying the agent to avoid
misdiagnosing the thickened fold as a severe gastric disease
upon screening EGD.
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